02/14/2025
3:29 PM | Quince Therapeutics (Subject)
Sofinnova Partners SAS (Filed by)
| Form SCHEDULE 13G | |
02/11/2025
4:41 PM | Hannah Brendan (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
4:43 PM | Quince Therapeutics (Issuer)
Ryan Charles S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
4:44 PM | Quince Therapeutics (Issuer)
Thye Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
6:29 PM | Quince Therapeutics (Issuer)
Senner Christopher J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
6:30 PM | Lamond David (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
6:32 PM | Bray June (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
6:33 PM | McLoughlin Margaret (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2024
3:01 PM | Quince Therapeutics (Filer)
| Form 424B5 | |
12/26/2024
11:15 PM | Quince Therapeutics (Filer)
| Form EFFECT | |
12/18/2024
3:03 PM | Quince Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
Get the Latest News and Ratings for QNCX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Quince Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
11/14/2024
5:55 AM | Quince Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
8:17 PM | Lamond David (Filed by)
Quince Therapeutics (Subject)
| Form SC 13D | |
11/13/2024
4:09 PM | Quince Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024
3:15 PM | Quince Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/03/2024
4:38 PM | Quince Therapeutics (Issuer)
Thye Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
4:51 PM | Quince Therapeutics (Issuer)
Ryan Charles S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
5:38 PM | Hannah Brendan (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
3:11 PM | Quince Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/06/2024
7:04 PM | Quince Therapeutics (Subject)
Sofinnova Partners SAS (Filed by)
| Form SC 13G/A | |
06/07/2024
8:08 PM | Lamond David (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
7:55 PM | Patni Rajiv (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
7:57 PM | Benatti Luca (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
7:59 PM | Bray June (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
8:00 PM | Quince Therapeutics (Issuer)
Senner Christopher J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
8:03 PM | Quince Therapeutics (Issuer)
RYAN UNA S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
8:04 PM | McLoughlin Margaret (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
4:17 PM | Quince Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2024
1:37 PM | Hannah Brendan (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
6:30 AM | Quince Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/24/2024
3:05 PM | Quince Therapeutics (Filer)
| Form DEFA14A | |
04/24/2024
3:10 PM | Quince Therapeutics (Filer)
| Form ARS | |
04/11/2024
3:39 PM | Quince Therapeutics (Filer)
| Form PRE 14A | |
04/01/2024
4:21 PM | Quince Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
04/01/2024
3:50 PM | Quince Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
Free QNCX Stock Alerts